Acute rhinosinusitis is one of the most common conditions in ambulatory care, causing over 30 million healthcare visits per year in the United States. 90–98% of cases are viral; only 0.5–2% of viral URIs progress to acute bacterial rhinosinusitis (ABRS). [1-2] The clinical challenge lies in distinguishing viral from bacterial etiology to guide appropriate antibiotic use.
1. History
- Onset and duration: When did symptoms begin? Were they preceded by a URI/cold? Have symptoms been continuous or did they improve then worsen ("double sickening")?
- Cardinal symptoms: Purulent nasal discharge, nasal obstruction/congestion, facial pain/pressure/fullness, hyposmia/anosmia
- Symptom characterization: Unilateral vs. bilateral facial pain, location (maxillary, frontal, periorbital), positional worsening (bending forward)
- Timing triggers: Three temporal patterns suggest bacterial etiology: [2-3]
- Persistent symptoms ≥10 days without improvement
- Severe symptoms (high fever ≥102°F/39°C + purulent discharge) for ≥3–4 consecutive days
- "Double sickening" — worsening after initial improvement over 3–4 days
- Associated symptoms: Headache, maxillary dental pain, ear fullness, cough (especially postnasal drip), fatigue, halitosis
- Important negatives: No visual changes, no periorbital swelling, no altered mental status, no severe unremitting headache
2. Alarm Features
- Orbital complications (most common complication): Periorbital edema/erythema, proptosis, impaired/painful extraocular movements, visual changes (diplopia, decreased acuity) [4-5]
- Intracranial complications: Severe headache, altered mental status, high persistent fevers, meningismus, seizures [5]
- Pott's puffy tumor: Frontal bone osteomyelitis — forehead swelling/tenderness, most common in adolescent males with frontal sinusitis [5]
- Cavernous sinus thrombosis: Bilateral orbital findings, cranial nerve palsies (III, IV, V, VI), high fever
- Systemic toxicity: Sepsis signs, hemodynamic instability
- Any of these findings warrant urgent CT/MRI, IV antibiotics, and ENT/neurosurgery consultation [4]
3. Medications
First-line antibiotics (when indicated): [1][4]
- Do NOT use macrolides (azithromycin, clarithromycin) or TMP-SMX as monotherapy — high resistance rates in S. pneumoniae and H. influenzae [1]
- Contraindicated medications: Oral corticosteroids are not recommended for uncomplicated ABRS. Antihistamines should be reserved only for patients with known allergic component. [6]
- Supportive therapies: Intranasal corticosteroids (e.g., fluticasone, mometasone), nasal saline irrigation, analgesics (acetaminophen/NSAIDs), topical decongestants (oxymetazoline ≤5 days to avoid rhinitis medicamentosa) [3][6]
4. Diet
- Hydration: Adequate fluid intake to thin secretions
- No specific dietary triggers are established for acute sinusitis
- Warm liquids and steam inhalation may provide symptomatic relief (anecdotal)
- In chronic/recurrent sinusitis, consider evaluation for aspirin-exacerbated respiratory disease (AERD) — patients should avoid aspirin/NSAIDs if diagnosed [7]
5. Review of Systems
- ENT: Nasal obstruction, rhinorrhea (anterior/posterior), anosmia, ear pain/fullness, sore throat, dental pain
- Eyes: Visual changes, periorbital swelling, eye pain (orbital complication screen)
- Neurologic: Headache severity/location, mental status changes, neck stiffness (intracranial complication screen)
- Pulmonary: Cough (postnasal drip vs. lower respiratory involvement), wheezing (asthma comorbidity)
- Constitutional: Fever pattern, malaise, weight loss (consider immunocompromised state or malignancy if chronic)
- Allergic: Seasonal pattern, known allergens, history of allergic rhinitis
6. Collateral History and Family History
- Collateral: Daycare exposure (children), sick contacts, recent dental procedures (odontogenic sinusitis), recent air travel or diving (barotrauma)
- Family history: Atopy, asthma, nasal polyps, cystic fibrosis, primary ciliary dyskinesia, immunodeficiency syndromes [7]
- Social context: Smoking status (active/passive), occupational exposures, cocaine use (nasal septal destruction)
7. Risk Factors
- For developing ABRS: Preceding viral URI, allergic rhinitis, anatomic abnormalities (deviated septum, polyps), smoking, dental infections [8]
- For resistant organisms (prompting amoxicillin-clavulanate over amoxicillin): [1][4]
- Age >65 years
- Recent hospitalization
- Antibiotic use within the past month
- Immunocompromised state
- Daycare attendance (children)
- Geographic regions with high endemic PNS S. pneumoniae (>10%)
- For complications: Immunosuppression, diabetes, frontal/sphenoid sinus involvement
8. Differential Diagnosis
- Viral URI (most common mimic) — self-limited, <10 days, bilateral symptoms
- Allergic rhinitis — sneezing, watery rhinorrhea, itchy eyes/nose, seasonal pattern, pale/boggy turbinates
- Migraine/tension headache — facial pain without purulent discharge or nasal obstruction
- Dental abscess/odontogenic sinusitis — unilateral maxillary symptoms, recent dental work, foul taste [4]
- Nasal foreign body (children) — unilateral foul-smelling discharge
- Invasive fungal sinusitis (cannot miss) — immunocompromised patients, black eschar on turbinates, rapidly progressive
- Sinonasal malignancy — unilateral obstruction, epistaxis, cranial nerve deficits, chronic course
- Granulomatosis with polyangiitis (GPA) — chronic sinusitis with bloody discharge, saddle nose deformity, systemic vasculitis features
- CSF leak — clear watery unilateral rhinorrhea, especially post-trauma
9. Past Medical History
- Prior episodes of sinusitis (recurrent = ≥4 episodes/year; chronic = ≥12 weeks)
- Asthma — modifies management; associated with nasal polyps and CRS [7]
- Cystic fibrosis, primary ciliary dyskinesia, immunodeficiency — all modify management per AAO-HNS 2025 guidelines [7]
- Prior sinus surgery or nasal procedures
- Allergic rhinitis, AERD (Samter's triad)
- Recent antibiotic use (resistance risk)
- Dental history — recent extractions, implants, root canals
10. Physical Exam
- Vital signs: Temperature (fever ≥39°C/102°F suggests bacterial), overall appearance
- Nasal exam: Anterior rhinoscopy — purulent discharge (especially unilateral), mucosal edema, polyps, septal deviation
- Facial exam: Tenderness to palpation over maxillary, frontal, or ethmoid sinuses; transillumination (low sensitivity/specificity)
- Oropharynx: Posterior pharyngeal purulent drainage (postnasal drip)
- Eye exam: Periorbital edema, erythema, proptosis, extraocular movements, visual acuity — critical to rule out orbital complications [4]
- Dental exam: Percussion tenderness of upper molars (odontogenic source)
- Neurologic: Mental status, cranial nerves (especially if concern for intracranial extension)
- Key finding: Purulent secretion in the nasal cavity on exam significantly increases the likelihood of bacterial etiology [8]
11. Lab Studies
- Routine labs are generally NOT indicated for uncomplicated acute rhinosinusitis [4]
- CRP and ESR: Somewhat useful for confirming bacterial maxillary sinusitis; ESR >10 mm/hr increases likelihood of bacterial cause. Point-of-care CRP may be helpful but is not widely available. [1][8]
- If complications suspected: CBC with differential, blood cultures, CRP/ESR, procalcitonin
- If immunodeficiency suspected (recurrent/chronic): Quantitative immunoglobulins (IgG, IgA, IgM, IgG subclasses), HIV testing [7]
- Sinus cultures: Not routine; reserved for treatment failure, complicated cases, or immunocompromised patients. Endoscopic middle meatus cultures preferred over swabs. [4]
12. Imaging
- Imaging is NOT recommended for uncomplicated acute rhinosinusitis — it cannot reliably distinguish viral from bacterial etiology [1][3]
- CT sinuses (without contrast): Indicated for: [4][8]
- Treatment failure after appropriate antibiotic course
- Suspected complications (orbital, intracranial)
- Recurrent sinusitis (≥4 episodes/year)
- Preoperative planning
- CT with contrast or MRI: When orbital or intracranial complications are suspected (abscess, cavernous sinus thrombosis) [4]
- Plain radiographs: Not recommended — poor sensitivity and specificity
- Key imaging findings: Air-fluid levels, complete sinus opacification, mucosal thickening >4 mm (nonspecific)
The following figure illustrates a clinical decision algorithm for evaluation and treatment of acute rhinosinusitis:
13. Special Tests
- Nasal endoscopy: Recommended for chronic/recurrent sinusitis or treatment failure; allows direct visualization of middle meatus and culture collection [7]
- Allergy testing: Skin prick or serum-specific IgE — indicated for recurrent or chronic sinusitis with suspected allergic component [7]
- Immune function testing: For recurrent/chronic sinusitis — immunoglobulin levels, vaccine response titers [7]
- Biopsy: If concern for malignancy, fungal sinusitis, or granulomatous disease
- Scoring systems: No widely validated severity scoring system exists for acute sinusitis; clinical criteria (IDSA, AAO-HNS) guide management [2]
14. ECG
- Not routinely indicated for sinusitis
- Consider ECG if prescribing fluoroquinolones (levofloxacin, moxifloxacin) in patients with risk factors for QT prolongation (elderly, electrolyte abnormalities, concurrent QT-prolonging medications)
15. Assessment
Clinical summary: Acute rhinosinusitis is a clinical diagnosis. The vast majority of cases are viral and self-limited (7–10 days). Bacterial superinfection (ABRS) is suggested by three distinct temporal patterns: persistent symptoms ≥10 days without improvement, severe onset (high fever + purulent discharge ≥3–4 days), or double sickening. [1-3]
Severity stratification:
- Mild/uncomplicated: Watchful waiting is appropriate for all patients with uncomplicated ABRS regardless of severity per the updated 2025 AAO-HNS guideline [7]
- Moderate: Consider antibiotics if symptoms persist or worsen after 3–5 days of watchful waiting [4]
- Severe/complicated: Immediate antibiotics and possible imaging/referral
Complications (rare but serious): Orbital cellulitis/abscess, intracranial abscess (epidural, subdural, brain), meningitis, cavernous sinus thrombosis, frontal bone osteomyelitis (Pott's puffy tumor) [1][5]
16. Treatment Plan
Initial management:
- Symptomatic care (all patients): Nasal saline irrigation, intranasal corticosteroids, analgesics (acetaminophen/ibuprofen), topical decongestants (oxymetazoline ≤5 days) [6]
- Watchful waiting: Valid initial strategy for uncomplicated ABRS — offer a "safety-net" prescription to fill if symptoms worsen or fail to improve by 7 days [6-7]
Antibiotic therapy (when indicated): [1][4][6]
- First-line: Amoxicillin 500 mg TID or 875 mg BID for 5–7 days (adults)
- If risk factors for resistance: Amoxicillin-clavulanate 875/125 mg BID
- Penicillin allergy: Doxycycline 100 mg BID or respiratory fluoroquinolone
- Treatment failure (no improvement by 7 days on antibiotics): Switch antibiotic class, obtain CT sinuses, consider ENT referral [4]
Key stewardship pearl: NNT for antibiotics = 7–18 to cure one patient faster, but NNH = 8 for adverse effects — most patients have more harm than benefit from antibiotics. [3][6]
17. Disposition
- Discharge (vast majority): Uncomplicated ABRS with or without antibiotics, reliable follow-up
- Observation/admission criteria:
- Signs of orbital or intracranial complications
- Systemic toxicity/sepsis
- Immunocompromised with severe presentation
- Need for IV antibiotics
- Failed outpatient therapy with worsening symptoms
- Specialist consultation triggers: [3-4]
- Suspected suppurative complications → ENT, ophthalmology, neurosurgery as indicated
- Recurrent sinusitis (≥4 episodes/year) → ENT, allergy/immunology
- Treatment failure after maximal medical therapy → ENT
- Immunocompromised patients with severe disease → infectious disease
18. Follow Up / Return Precautions
- Follow-up timing: Reassess in 7 days if on watchful waiting; reassess in 3–5 days (per IDSA) or 7 days (per AAO-HNS) if on antibiotics and not improving [6]
- Return immediately for:
- Visual changes, eye swelling, or eye pain
- Severe or worsening headache
- High fever unresponsive to antipyretics
- Altered mental status, neck stiffness
- Forehead swelling
- Symptoms worsening despite antibiotics
- Patient counseling:
- Most sinusitis is viral and resolves in 7–10 days without antibiotics [1]
- Antibiotics do not speed recovery in viral sinusitis and carry side effects
- Continue nasal saline irrigation and intranasal steroids for symptom relief
- Avoid smoking and secondhand smoke exposure
- Expected recovery: Symptoms typically begin improving within 7–10 days; full resolution may take 2–3 weeks. If symptoms persist beyond 12 weeks, evaluation for chronic rhinosinusitis is warranted. [7]
References
1. Acute Rhinosinusitis: Rapid Evidence Review. — Butler FM, Hernandez DR. American Family Physician. 2025.
2. Acute Rhinosinusitis: Rapid Evidence Review. — Butler FM, Hernandez DR. American Family Physician. 2025.
3. Acute Rhinosinusitis: Rapid Evidence Review. — Butler FM, Hernandez DR. American Family Physician. 2025.
4. Antibiotic Use in Acute Upper Respiratory Tract Infections. — Sur DKC, Plesa ML. American Family Physician. 2022.
5. Antibiotic Use in Acute Upper Respiratory Tract Infections. — Sur DKC, Plesa ML. American Family Physician. 2022.
6. Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention. — Harris AM, Hicks LA, Qaseem A. Annals of Internal Medicine. 2016.
7. Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention. — Harris AM, Hicks LA, Qaseem A. Annals of Internal Medicine. 2016.
8. Clinical Practice Guideline: Adult Sinusitis Update. — Payne SC, McKenna M, Buckley J, et al. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 2025.
9. Clinical Practice Guideline: Adult Sinusitis Update. — Payne SC, McKenna M, Buckley J, et al. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 2025.
10. Clinical Practice Guideline for the Diagnosis and Management of Acute Bacterial Sinusitis in Children Aged 1 to 18 Years. — Wald ER, Applegate KE, Bordley C, et al. Pediatrics. 2013.
11. Clinical Practice Guideline for the Diagnosis and Management of Acute Bacterial Sinusitis in Children Aged 1 to 18 Years. — Wald ER, Applegate KE, Bordley C, et al. Pediatrics. 2013.
12. Acute Sinusitis in Adults. — Rosenfeld RM. The New England Journal of Medicine. 2016.
13. Acute Sinusitis in Adults. — Rosenfeld RM. The New England Journal of Medicine. 2016.
14. Executive Summary of the Clinical Practice Guideline on Adult Sinusitis Update. — Payne SC, McKenna M, Buckley J, et al. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 2025.
15. Executive Summary of the Clinical Practice Guideline on Adult Sinusitis Update. — Payne SC, McKenna M, Buckley J, et al. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 2025.
16. Current Concepts in Adult Acute Rhinosinusitis. — Aring AM, Chan MM. American Family Physician. 2016.
17. Current Concepts in Adult Acute Rhinosinusitis. — Aring AM, Chan MM. American Family Physician. 2016.